Trial Profile

A Randomised phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advanced or recurrent gastric cancer resistant to S-1.

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 13 May 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

04 May 2020 Results (n=163) of exploratory analysis comparing efficacy and safety of IRI-based chemotherapy between subgroups progressive disease and early relapse for second-line advanced gastric cancer were published in the European Journal of Cancer
20 Jan 2018 Results of an exploratory subgroup analysis from early relapse patients presented at the 2018 Gastrointestinal Cancers Symposium
26 Jan 2013 Results presented at the 2013 Gastrointestinal Cancers Symposium.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com